Orthopedic Growth Factors Market Analysis | China | 2016-2022 | MedCore

Orthopedic Growth Factors Market Analysis | China | 2016-2022 | MedCore


Growth factors are a group of small, soluble proteins that bind onto cell surface receptors, triggering a series of signals that regulate the body’s ability to grow, renew and heal. Due to the regenerative properties of growth factors, they have been exploited for bone healing in orthopedic applications.

  • Year: 2016
  • Scope: 2012-2022
  • Region: China
  • Published Date: 2/1/2016
  • Pages: 31
  • Type: MedCore

As of 2015 there has only been one such product offered on the market in China: rhBMP-2 manufactured by Shanghai Rebone. There are few BMP products available in the world. For example, one is Infuse® by Medtronic. Stryker’s OP-1™, which had been sold to Olympus Biotech, is no longer available as Olympus Biotech ceased sales on May 31st, 2014. Other products include Wright’s Augment®, and less known brands from Asian manufacturers (notably Korean). INFUSE® and OP-1™ are two different forms of bone morphogenic proteins (BMPs) that belong to a larger family of proteins called transforming growth factor ?s.
BMPs were first discovered by Marshall Urist in 1965. Since the discovery, there have been 20 regulatory protein molecules identified to date. BMPs specifically regulate the production of bone within the human body. These proteins are functionally relevant during embryonic development in the formation of the skeleton. Urist established that demineralized bone matrix, when implanted in ectopic sites in rodents, helped to induce bone regeneration. Urist discovered that a single dose of BMP combined with autograft can repair non-union fractures that are 3 cm to 14 cm in size.
BMPs are involved in many signaling pathways including those that cause increases in parathyroid hormone levels and the expression of osteocalcin, which stimulates osteoblast differentiation. These groundbreaking findings led to the isolation and cloning of several BMPs, which have been exploited for their healing properties.

The "Chinese Market Report Suite for Orthopedic Biomaterials 2016 - MedSuite" includes analysis on the following companies currently active in this market:
Allgens Medical
Biolu Biomaterials
Bloomage Freda Biopharm
Datsing Biotech
DePuy Synthes
Guona Keji
Hanghzhou Gallop
Harbin Gloria Pharmaceutical
Jinxingda Company (Tianjin)
Kunming Baker Norton
Kunming Baker Norton
Meiji Seika
Osteolink Biomaterials
Rebone Biomaterials
Shanghai Anjiu Biotechnology
Shanghai HaoHai
Shanghai Jingfeng Pharmaceutical
Shanxi OsteoRad Biomaterial
Wright Medical
Xin Kang Chen

*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers